Treatment of Patients With Advanced Rectum Cancer With Capecitabine and Oxaliplatin Before, Under and After Radiation and With Adding Cetuximab to K-RAS Wild-type Patients


NCT00964457

Interventional

Phase 2

Unknown status
response rate to adding cetuximab, oxaliplatin and capecitabine to radiation for advanced rectum cancer
Aug 31,2009
All
18 Years
N/A
60

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.